Jain Chung
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Pharmacology top 0.5%
- Pharmacology and Obesity Treatment
Papers in
-
- HIV/AIDS Research and Interventions 8
- HIV/AIDS drug development and treatment 7
- Virology 8
- HIV Research and Treatment 8
- Co-authors
- Miklos Salgo (9 shared papers)Ralph DeMasi (6 shared papers)Charles Lucas (2 shared papers)Jonathan Hauptman (2 shared papers)Charles H. Halsted (1 shared paper)David C. Robbins (1 shared paper)Douglas C. Heimburger (1 shared paper)Mario DiGirolamo (1 shared paper)
- Journals
- Journal of Biopharmaceutical Statistics (2 papers)HIV Clinical Trials (2 papers)Clinical Infectious Diseases (1 paper)JAMA (1 paper)HIV Medicine (1 paper)
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Jain Chung
14 papers receiving 2.2k citations
Jain Chung's Hit Papers
Peers
Comparison fields: 5 of 111
- Virology 826
- Pharmacology 991
- Infectious Diseases 852
- Endocrinology, Diabetes and Metabolism 532
- Pharmacy 96
Countries citing papers authored by Jain Chung
This map shows the geographic impact of Jain Chung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jain Chung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jain Chung more than expected).
Fields of papers citing papers by Jain Chung
This network shows the impact of papers produced by Jain Chung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jain Chung. The network helps show where Jain Chung may publish in the future.
Co-authors
The 25 scholars most cited alongside Jain Chung, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Enfuvirtide, an HIV-1 Fusion Inhibitor, for Drug-Resistant HIV Infection in North and South America Hit paper breakdown → | 2003 | 716 |
| 2 | Weight Control and Risk Factor Reduction in Obese Subjects Treated for 2 Years With Orlistat Hit paper breakdown → | 1999 | 705 |
| 3 | 1998 | 472 | |
| 4 | 2004 | 362 | |
| 5 | 2006 | 37 | |
| 6 | 1986 | 17 | |
| 7 | 2005 | 16 | |
| 8 | 2010 | 12 | |
| 9 | 2008 | 10 | |
| 10 | 2006 | 9 | |
| 11 | 2000 | 3 | |
| 12 | 2006 | 2 | |
| 13 | 2006 | 1 | |
| 14 | 1989 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2020 | 0 |
About Jain Chung
Jain Chung is a scholar working on Infectious Diseases, Virology, Surgery, Pharmacology and Public Health, Environmental and Occupational Health, having authored 16 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (8 papers), HIV/AIDS drug development and treatment (7 papers), HIV-related health complications and treatments (2 papers), Pharmacology and Obesity Treatment (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Forest ecology and management (1 paper) and Forest Biomass Utilization and Management (1 paper). The work is most often cited by research in Virology (826 citations), Pharmacology (991 citations), Infectious Diseases (852 citations), Endocrinology, Diabetes and Metabolism (532 citations) and Pharmacy (96 citations). Jain Chung has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Miklos Salgo, Ralph DeMasi, Charles Lucas, Jonathan Hauptman, Charles H. Halsted, David C. Robbins, Douglas C. Heimburger, Mario DiGirolamo, Michael Davidson and Steven B. Heymsfield. Their work appears in journals such as Journal of Biopharmaceutical Statistics, HIV Clinical Trials, Clinical Infectious Diseases, JAMA and HIV Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.